About Bellwether Bio
Bellwether Bio is a company based in Seattle (United States) founded in 2016 was acquired by Guardant Health in March 2019.. Bellwether Bio has raised $2.8 million across 2 funding rounds from investors including Guardant Health, The W Fund and WRF Capital. Bellwether Bio operates in a competitive market with competitors including Guardant Health, GRAIL, Color, Delfi Diagnostics and BillionToOne, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.8 M (USD)
in 2 rounds
-
Latest Funding Round
$175 K (USD), Debt – Conventional
Apr 18, 2018
-
Investors
Guardant Health
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Guardant Health
(Mar 27, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bellwether Bio
Bellwether Bio has successfully raised a total of $2.8M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $175 thousand completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $175,000
-
First Round
First Round
(06 Apr 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2018 | Amount | Debt – Conventional - Bellwether Bio | Valuation |
investors |
|
| Apr, 2017 | Amount | Seed - Bellwether Bio | Valuation | The W Fund , Washington Research Foundation |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bellwether Bio
Bellwether Bio has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Guardant Health, The W Fund and WRF Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in Washington-based startups by WRF Capital.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bellwether Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bellwether Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bellwether Bio Comparisons
Competitors of Bellwether Bio
Bellwether Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Color, Delfi Diagnostics and BillionToOne, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Bellwether Bio
When was Bellwether Bio founded?
Bellwether Bio was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Bellwether Bio located?
Bellwether Bio is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Is Bellwether Bio a funded company?
Bellwether Bio is a funded company, having raised a total of $2.8M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.8M, raised on Apr 06, 2017.
What does Bellwether Bio do?
Bellwether Bio was founded in 2016 and is headquartered in Seattle, United States. The company operates in the biotechnology sector, focusing on cancer diagnostics through a platform that analyzes nucleosome patterns in cell-free DNA to identify tissue origins. This technology is also applied to assess tumor severity and size. Analyses are conducted using standard sequencing instruments, requiring no additional materials. The underlying technology was developed at the University of Washington.
Who are the top competitors of Bellwether Bio?
Bellwether Bio's top competitors include Guardant Health, GRAIL and BillionToOne.
Who are Bellwether Bio's investors?
Bellwether Bio has 4 investors. Key investors include Guardant Health, The W Fund, WRF Capital, and Bioeconomy Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.